FRMD6 and central nervous system cancer: Analyses of the TCGA-GBM data through the cBioPortal for Cancer Genomics generated little information on FRMD6 deletions/amplifications and expression levels whereas analyses of the TCGA-GBM data through OASIS (http://www.oasis-genomics.org/) indicated that FRMD6 is deleted in 3.3% (19/577) of GBM cases and in 0.8% (3/371) cases of lower grade glioma.